C
CUV
CLINUVEL PHARMACEUT.
11.67
-0.04-0.34%Closed16:10 02/20 AEDT
OPEN/PREV CLOSE11.69/11.71
TODAY RANGE11.36-11.87
VOL76.08K
MARKET CAP585.84M
52 WEEK RANGE9.41-14.00
AVG VOL (3M)113.98K
% TURNOVER0.14%
TURNOVER886.01K
P/E (TTM)16.25
% RANGE4.36%
EPS(TTM)0.718
P/E(FORWARD)15.69
P/B2.429
BVPS4.804
DIVIDEND0.050
P/S6.16
BETA--
DIV YIELD0.43%
FREE FLOAT MKT CAP488.22M
SHARES OUTSTANDING50.20M
NEXT EARNINGS02/25-03/02
FREE FLOAT41.84M
LOT SIZE1
EX-DATE09/04/2025
News
Press Releases
Financial Reports
Profile
ASX·2d ago
CLINUVEL Investor Webinar
ASX·02/01 21:32
Clinical & Financial Update
ASX·01/14 22:13
Managing Director Letter to Shareholders
The Motley Fool·01/11 23:43
This ASX 300 stock is racing 6% higher on exciting news
ASX·01/11 21:44
CLINUVEL - injectable peptide platform in preclinical study
ASX·01/07 22:45
SCENESSE efficacy in vitiligo - new cases presented at RDTC
ASX·01/01 22:24
Notification of cessation of securities - CUV
ASX·12/18/2025 21:35
CLINUVEL progresses Level II ADR upgrade, Nasdaq uplist
The Motley Fool·12/08/2025 02:57
Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today
ASX·12/07/2025 21:35
CLINUVEL expands Singapore RD&I Centre
Dow Jones·12/04/2025 21:10
*Clinuvel Pharmaceuticals Price Target Raised 12% to A$41.85/Share by Jefferies
ASX·12/01/2025 23:39
CLINUVEL advances NEURACTHEL Instant, EU filing mid-2026
ASX·11/13/2025 21:28
Stifel Healthcare Conference presentation
Dow Jones·11/11/2025 23:05
*Clinuvel Pharmaceuticals Raised to Spec Buy From Hold by Morgans >CUV.AU
ASX·11/11/2025 21:32
Change in substantial holding
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others